Breaking News Instant updates and real-time market news.

CBAY

CymaBay

$1.34

-4.21 (-75.86%)

08:45
11/26/19
11/26
08:45
11/26/19
08:45

CymaBay downgraded to Neutral from Buy at Roth Capital

Roth Capital analyst Yasmeen Rahimi downgraded CymaBay to Neutral from Buy with a price target of $2, down from $22, following the company's announcement of a clinical halt for seladelpar and subsequent call providing more details of histology findings. She walked away from CymaBay update call with more understanding of the atypical histological findings, but still remains uncertain regarding the cause and how the clinical halt will be resolved, Rahimi tells investors. She prefers to step to the sidelines while awaiting more clarity regarding timelines and casualty, the analyst added.

CBAY CymaBay
$1.34

-4.21 (-75.86%)

11/26/19
SBSH
11/26/19
NO CHANGE
Target $2
SBSH
Buy
CymaBay price target lowered to $2 from $12 at Citi
Citi analyst Joel Beatty lowered his price target for CymaBay Therapeutics to $2 from $12 after the company halted the clinical development of seladelpar. The analysts, however, keeps a Buy rating on the shares. He now values CymaBay based on cash, with no pipeline credit. Per his calculations, CymaBay currently has $3.14 per share in cash.
11/26/19
CANT
11/26/19
DOWNGRADE
Target $2
CANT
Neutral
CymaBay downgraded to Neutral from Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Eliana Merle downgraded CymaBay Therapeutics to Neutral from Overweight with a price target of $2, down from $20. Though shares are trading currently below cash of $3 per share, the "unexpected histological effects present a challenge for further clinical development," Merle tells investors in a research note.
11/26/19
HCWC
11/26/19
DOWNGRADE
Target $2
HCWC
Neutral
CymaBay downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright analyst Ed Arce downgraded CymaBay Therapeutics to Neutral from Buy with a price target of $2, down from $16, after the company halted all clinical development of lead drug seladelpar. The analyst believes the drug is "probably done." However, he believes further share downside like "likely limited" with the company's current cash at approximately $200M or about $2.91 per share.
11/26/19
RAJA
11/26/19
DOWNGRADE
RAJA
Market Perform
CymaBay double downgraded at Raymond James after seladelpar setback
As previously reported, Raymond James analyst Steven Seedhouse double downgraded CymaBay to Market Perform from Strong Buy following the "unexpected setback" for seladelpar that has resulted in the company terminating or halting all programs for the drug. He cut his view on the probability of success in primary biliary cholangitis, the remaining indication being studied, to 25% from 90% and sees uncertainty for any path forward for the lead program, Seedhouse tells investors.

TODAY'S FREE FLY STORIES

SGEN

Seattle Genetics

$111.78

-2.19 (-1.92%)

12:53
12/11/19
12/11
12:53
12/11/19
12:53
Recommendations
Seattle Genetics analyst commentary  »

Seattle Genetics data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

TWTR

Twitter

$30.16

0.31 (1.04%)

, SQ

Square

$65.52

-0.3 (-0.46%)

12:48
12/11/19
12/11
12:48
12/11/19
12:48
On The Fly
#SocialStocks: YouTube updates harassment policy, Snapchat 'deepfake' GIFs »

Welcome to…

TWTR

Twitter

$30.16

0.31 (1.04%)

SQ

Square

$65.52

-0.3 (-0.46%)

FB

Facebook

$201.03

0.13 (0.06%)

AMZN

Amazon.com

$1,738.68

-0.47 (-0.03%)

SNAP

Snap

$14.15

0.065 (0.46%)

GOOGL

Alphabet Class A

$1,342.74

-0.3 (-0.02%)

GOOG

Alphabet

$1,344.23

-0.27 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 26

    Feb

CIEN

Ciena

$35.15

0.45 (1.30%)

, LOVE

Lovesac

$14.52

0.08 (0.55%)

12:48
12/11/19
12/11
12:48
12/11/19
12:48
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

CIEN

Ciena

$35.15

0.45 (1.30%)

LOVE

Lovesac

$14.52

0.08 (0.55%)

VERU

Veru

$2.27

-0.03 (-1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 17

    Dec

  • 19

    Dec

LULU

Lululemon

$232.23

2.67 (1.16%)

, NDSN

Nordson

$165.56

-0.19 (-0.11%)

12:48
12/11/19
12/11
12:48
12/11/19
12:48
Earnings
Notable companies reporting after market close »

Notable companies…

LULU

Lululemon

$232.23

2.67 (1.16%)

NDSN

Nordson

$165.56

-0.19 (-0.11%)

OXM

Oxford Industries

$74.50

-1.46 (-1.92%)

MESA

Mesa Air

$9.04

-0.04 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

CSCO

Cisco

$44.29

0.18 (0.41%)

, CMCSA

Comcast

$42.04

-0.73 (-1.71%)

12:45
12/11/19
12/11
12:45
12/11/19
12:45
Hot Stocks
Cisco announces 'Internet for the Future' strategy »

Cisco (CSCO) unveiled…

CSCO

Cisco

$44.29

0.18 (0.41%)

CMCSA

Comcast

$42.04

-0.73 (-1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 08

    Jan

  • 12

    Feb

ADI

Analog Devices

$115.90

1.48 (1.29%)

12:45
12/11/19
12/11
12:45
12/11/19
12:45
Options
Analog Devices call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$313.73

0.18 (0.06%)

12:45
12/11/19
12/11
12:45
12/11/19
12:45
Hot Stocks
Gundlach says in next recession, U.S. will be worst stock market in world »

DoubleLine CEO Jeffrey…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$313.73

0.18 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
12/11/19
12/11
12:45
12/11/19
12:45
General news
FOMC forecast revisions »

FOMC forecast revisions…

PLCE

Children's Place

$54.72

-15.95 (-22.57%)

12:44
12/11/19
12/11
12:44
12/11/19
12:44
Downgrade
Children's Place rating change  »

Children's Place…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$313.73

0.18 (0.06%)

12:41
12/11/19
12/11
12:41
12/11/19
12:41
Hot Stocks
Gundlach says Hillary Clinton would be strongest Democratic candidate »

DoubleLine CEO Jeffrey…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$313.73

0.18 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNMD

Conmed

$112.16

(0.00%)

12:41
12/11/19
12/11
12:41
12/11/19
12:41
Hot Stocks
Conmed VP John Kennedy sells almost $700K in company shares »

Conmed VP John Kennedy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$313.71

0.16 (0.05%)

12:40
12/11/19
12/11
12:40
12/11/19
12:40
Hot Stocks
Gundlach says Trump winning reelection more positive than negative for market »

DoubleLine CEO Jeffrey…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$313.71

0.16 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$313.70

0.15 (0.05%)

12:40
12/11/19
12/11
12:40
12/11/19
12:40
Hot Stocks
Gundlach says Elizabeth Warren is 'done' amid collapsing poll numbers »

DoubleLine CEO Jeffrey…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$313.70

0.15 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETFC

E-Trade

$45.57

0.2 (0.44%)

12:39
12/11/19
12/11
12:39
12/11/19
12:39
Hot Stocks
E-Trade says rumor that company has been approached 'patently false' »

Says the rumor that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 18

    Dec

  • 26

    Feb

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$313.72

0.17 (0.05%)

12:38
12/11/19
12/11
12:38
12/11/19
12:38
Hot Stocks
Gundlach says Bloomberg 'has no chance' to win nomination »

DoubleLine CEO Jeffrey…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$313.72

0.17 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$313.75

0.2 (0.06%)

12:36
12/11/19
12/11
12:36
12/11/19
12:36
Hot Stocks
Gundlach says his 'base case' is President Trump wins reelection »

DoubleLine CEO Jeffrey…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$313.75

0.2 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$0.00

(0.00%)

12:33
12/11/19
12/11
12:33
12/11/19
12:33
Hot Stocks
Nestle to sell U.S. ice cream business to Froneri JV in $4B transaction »

Nestle announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGM

LogMeln

$79.62

5.66 (7.65%)

12:26
12/11/19
12/11
12:26
12/11/19
12:26
Periodicals
PE firms in talks to buy LogMeln, Bloomberg says »

Private equity firm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANF

Abercrombie & Fitch

$16.68

-1.1 (-6.19%)

12:25
12/11/19
12/11
12:25
12/11/19
12:25
Options
Abercrombie & Fitch call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$0.00

(0.00%)

12:23
12/11/19
12/11
12:23
12/11/19
12:23
Periodicals
Nestle close to selling U.S. ice cream unit to Froneri JV, Bloomberg says »

The deal would value the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$313.78

0.23 (0.07%)

12:22
12/11/19
12/11
12:22
12/11/19
12:22
Hot Stocks
Gundlach says now is time to exit corporate bond market »

DoubleLine CEO Jeffrey…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$313.78

0.23 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
12/11/19
12/11
12:17
12/11/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
12/11/19
12/11
12:16
12/11/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATXI

Avenue Therapeutics

$6.58

0.13 (2.02%)

12:14
12/11/19
12/11
12:14
12/11/19
12:14
Recommendations
Avenue Therapeutics analyst commentary  »

H.C. Wainwright sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XCUR

Exicure

$3.18

0.19 (6.37%)

12:12
12/11/19
12/11
12:12
12/11/19
12:12
Recommendations
Exicure analyst commentary  »

H.C. Wainwright…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.